-
| ISIN | US81749D1072 |
|---|---|
| CurrencyCode | USD |
| Exchange | NASDAQ |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Beta | nan |
|---|---|
| Dividend Yield | 0.0% |
| Target Price | 4.63 |
| PE Ratio | None |
| Market Cap | 111M |
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SERA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024